General Information of the Compound
| Compound ID |
CP0391203
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(5-benzoyl-4-phenyl-1,3-thiazol-2-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
305851-70-1
AB00666822-01
AC1LJXJU
AKOS001011200
AQ-360/10877054
BDBM50308494
CHEMBL600232
MCULE-6547152460
MolPort-000-184-059
N-(5-Benzoyl-4-phenylthiazol-2-yl)benzamide
N-(5-benzoyl-4-phenyl-1,3-thiazol-2-yl)benzamide
Oprea1_574683
ZINC626960
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H16N2O2S
|
||||||||||||||||||
| Molecular Weight |
384.46
|
||||||||||||||||||
| Canonical SMILES |
O=C(Nc1nc(c(s1)C(=O)c1ccccc1)-c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H16N2O2S/c26-20(17-12-6-2-7-13-17)21-19(16-10-4-1-5-11-16)24-23(28-21)25-22(27)18-14-8-3-9-15-18/h1-15H,(H,24,25,27)
Show/Hide
|
||||||||||||||||||
| InChIKey |
PCQHQQZQXRSVDE-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01278, Adenosine receptor A2b
Protein ID: PT01279, Adenosine receptor A3
Clinical Information about the Compound